US · VEEV · SOFTWARE - APPLICATION
Veeva Systems Inc. (VEEV) intrinsic value and stock valuation
$266.22as of 2026-11-21 · Mkt cap 34.68B
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Veeva Systems Inc. DCF and intrinsic value
InvestorsCraft values VEEV with the Chepakovich two-stage DCF model — currently rated overvalued. How the model works · Run your own DCF prefilled from VEEV’s statements →
Veeva Systems Inc. Graham Number
Graham Number: $74.22d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2012–2026, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
- Cardinal Health, Inc. (CAH) $272.81
- argenx SE (ARGX) $925.70
- Edwards Lifesciences Corporation (EW) $101.85
- Becton, Dickinson and Company (BDX) $212.78
- IDEXX Laboratories, Inc. (IDXX) $676.21
- Haleon plc (HLN) $9.07
- Agilent Technologies, Inc. (A) $170.38
- IQVIA Holdings Inc. (IQV) $245.82
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $3.2B | $2.75B | $2.36B | $2.16B | $1.85B |
| Operating income | $916.4M | $691.4M | $429.3M | $459.1M | $505.5M |
| Net income | $908.9M | $714.1M | $525.7M | $487.7M | $427.4M |
| EPSd | $5.44M | $4.32M | $3.22M | $3M | $2.63M |
| Operating cash flow | $1.42B | $1.09B | $911.3M | $780.5M | $764.5M |
| Capital expenditure | -$-29.13M | -$-20.52M | -$-26.2M | -$-13.51M | -$-14.21M |
| Free cash flow | $1.39B | $1.07B | $885.1M | $767M | $750.3M |
| Total assets | $8.98B | $7.34B | $5.91B | $4.8B | $3.82B |
| Total debt | $95.9M | $75.8M | $55.8M | $61M | $54.6M |
| Net debt | -$-1.33B | -$-1.04B | -$-647.71M | -$-825.49M | -$-1.08B |
| Total equity | $7.21B | $5.83B | $4.64B | $3.72B | $2.91B |
| Cash and short-term investments | $6.56B | $5.15B | $4.03B | $3.1B | $2.38B |
Income statement
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $3.2B | $2.75B | $2.36B | $2.16B | $1.85B |
| Cost of revenue | $782M | $699.6M | $677.3M | $609.4M | $503.7M |
| Gross profit | $2.41B | $2.05B | $1.69B | $1.55B | $1.35B |
| Research and development expenses | $767.4M | $693.1M | $629M | $520.3M | $382M |
| Selling, general and administrative expenses | $729.5M | $662.5M | $628M | $566.3M | $459.6M |
| Other expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating expenses | $1.5B | $1.36B | $1.26B | $1.09B | $841.6M |
| Cost and expenses | $2.28B | $2.06B | $1.93B | $1.7B | $1.35B |
| Interest income | $0.00 | $208M | $133.8M | $45.9M | $14.7M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation and amortization | $50.5M | $39.4M | $32.6M | $29.1M | $27.5M |
| Ebitda | $1.24B | $958.8M | $620.7M | $538.2M | $539.8M |
| Operating income | $916.4M | $691.4M | $429.3M | $459.1M | $505.5M |
| Total other income/expenses, net | $278.1M | $228M | $158.7M | $50M | $6.82M |
| Income before tax | $1.19B | $919.4M | $588M | $509.1M | $512.3M |
| Income tax expense | $285.6M | $205.2M | $62.3M | $21.4M | $84.9M |
| Net income | $908.9M | $714.1M | $525.7M | $487.7M | $427.4M |
| Weighted average shares outstanding | $163.7M | $161.9M | $160.5M | $155.4M | $153.3M |
| Weighted average diluted shares outstanding | $167M | $165.2M | $163.5M | $162.4M | $162.3M |
Balance sheet
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $6.56B | $5.15B | $4.03B | $3.1B | $2.38B |
| Net receivables | $1.31B | $1.06B | $888.5M | $785.2M | $694.4M |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current assets | $8B | $6.31B | $5B | $3.97B | $3.11B |
| Property, plant and equipment, net | $145.9M | $119.8M | $104.1M | $105.2M | $104.1M |
| Goodwill and intangible assets | $470.2M | $484.3M | $502.9M | $522.4M | $541.8M |
| Long-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current assets | $981.7M | $1.03B | $907.7M | $835M | $709.3M |
| Total assets | $8.98B | $7.34B | $5.91B | $4.8B | $3.82B |
| Accounts payable | $37.6M | $30.5M | $31.5M | $41.7M | $20.4M |
| Short-term debt | $12.2M | $9.97M | $9.33M | $11.3M | $11M |
| Deferred revenue | $1.49B | $1.27B | $1.05B | $869.3M | $731.8M |
| Total current liabilities | $1.64B | $1.4B | $1.18B | $1.01B | $840.8M |
| Long-term debt | $83.7M | $65.8M | $46.4M | $49.7M | $43.6M |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $127.5M | $109M | $87.2M | $81.2M | $64.1M |
| Capital lease obligations | $95.9M | $75.8M | $55.8M | $61M | $54.6M |
| Total liabilities | $1.76B | $1.51B | $1.27B | $1.09B | $904.8M |
| Common stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Retained earnings | $4.36B | $3.45B | $2.74B | $2.21B | $1.73B |
| Accumulated other comprehensive income (loss) | $8.16M | -$-8.42M | -$-10.64M | -$-31.13M | -$-11.96M |
| Total equity | $7.21B | $5.83B | $4.64B | $3.72B | $2.91B |
| Total investments | $5.14B | $4.03B | $3.32B | $2.22B | $1.24B |
| Total debt | $95.9M | $75.8M | $55.8M | $61M | $54.6M |
| Net debt | -$-1.33B | -$-1.04B | -$-647.71M | -$-825.49M | -$-1.08B |
Cash flow statement
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Net income | $908.9M | $714.1M | $525.7M | $487.7M | $427.4M |
| Depreciation and amortization | $50.5M | $50.9M | $37.2M | $37.7M | $37M |
| Stock-based compensation | $472.7M | $0.00 | $0.00 | $0.00 | $0.00 |
| Change in working capital | -$-91.94M | $7.62M | $60.8M | $7.34M | $20.7M |
| Accounts receivable | -$-254.55M | -$-168.97M | -$-104M | -$-91.08M | -$-83.08M |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Accounts payable | $6.08M | -$-1.96M | -$-10.23M | $21.4M | -$-3M |
| Net cash provided by operating activities | $1.42B | $1.09B | $911.3M | $780.5M | $764.5M |
| Investments in property, plant and equipment | -$-29.13M | -$-20.52M | -$-26.2M | -$-13.51M | -$-14.21M |
| Acquisitions, net | $0.00 | $0.00 | $0.00 | $0.00 | -$-7.78M |
| Net cash used for investing activities | -$-1.1B | -$-700.14M | -$-1.08B | -$-1.01B | -$-346.15M |
| Common stock issued | $253.9M | $105.5M | $62.7M | $43.7M | $51.5M |
| Common stock repurchased | -$-169.95M | $0.00 | $0.00 | $0.00 | $0.00 |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash used for financing activities | -$-9.33M | $26.1M | -$-16.19M | -$-19.38M | -$-4.14M |
| Net change in cash | $302.5M | $414.3M | -$-182.98M | -$-251.57M | $409.5M |
| Cash at end of period | $1.42B | $1.12B | $706.7M | $889.7M | $1.14B |
| Operating cash flow | $1.42B | $1.09B | $911.3M | $780.5M | $764.5M |
| Capital expenditure | -$-29.13M | -$-20.52M | -$-26.2M | -$-13.51M | -$-14.21M |
| Free cash flow | $1.39B | $1.07B | $885.1M | $767M | $750.3M |
Line items
Line items
Line items
About Veeva Systems Inc.
Veeva Systems Inc. is a leading provider of cloud-based software solutions, exclusively dedicated to the global life sciences industry. Its extensive operational presence spans across North America, Europe, the Asia Pacific region, the Middle East, Africa, and Latin America. The company's product portfolio is primarily structured around two major offerings. First, the Veeva Commercial Cloud delivers an integrated suite of software, data, and analytics tools designed to optimize commercial operations. This includes vital applications such as Veeva Customer Relationship Management (CRM) and its specialized Medical CRM, Veeva Closed Loop Marketing (CLM), sophisticated analytics via Veeva CRM MyInsights, approved email communication with Veeva CRM Approved Email, digital engagement tools like Veeva CRM Engage, commercial alignment through Veeva Align, event management capabilities with Veeva CRM Events Management, data warehousing solutions (Veeva Nitro), data services (Veeva OpenData, Veeva Link), master data management (Veeva Network), advanced analytical insights (Veeva Crossix, Veeva Data Cloud), and patient engagement platforms (MyVeeva for Patients). Secondly, Veeva Vault provides a robust collection of cloud-native enterprise content and data management applications. These applications are engineered to support both critical commercial functions—encompassing sales, marketing, and medical content and communications—and comprehensive research and development processes, including clinical trials, regulatory compliance, quality management, and patient safety. Beyond its software, Veeva offers a wide array of professional and support services. These range from strategic implementation and deployment planning, project management, and detailed requirements analysis to solution design and configuration. They also include system environment management and deployment, expert consulting for business process transformation related to Veeva solutions, technical guidance on data migration and systems integrations, comprehensive training programs, and ongoing managed services such as outsourced systems administration. Tracing its origins, the company was incorporated in 2007 as Verticals onDemand, Inc., and subsequently rebranded to Veeva Systems Inc. in April 2009. Its corporate headquarters are situated in Pleasanton, California.
- CEO
- Peter Gassner
- Employees
- 7.93K
- Beta
- 0.94
Explore
Frequently asked questions
What is the intrinsic value of Veeva Systems Inc. (VEEV)?
Veeva Systems Inc. (VEEV) is currently overvalued based on the InvestorsCraft IC model — IC value is 20–50% below the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is VEEV undervalued?
VEEV trades at a price of $266.22 (Nov 21, 2026): overvalued — IC value is 20–50% below the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.